Advertisement

Journal of Neural Transmission

, Volume 114, Issue 5, pp 527–537 | Cite as

How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II

  • A. Schmitt
  • M. Bauer
  • H. Heinsen
  • W. Feiden
  • The Consortium of Brainnet Europe II
  • P. Falkai
  • I. Alafuzoff
  • T. Arzberger
  • S. Al-Sarraj
  • J. E. Bell
  • N. Bogdanovic
  • W. Brück
  • H. Budka
  • I. Ferrer
  • G. Giaccone
  • G. G. Kovacs
  • D. Meyronet
  • M. Palkovits
  • P. Parchi
  • E. Patsouris
  • R. Ravid
  • R. Reynolds
  • P. Riederer
  • W. Roggendorf
  • A. Schwalber
  • D. Seilhean
  • H. Kretzschmar
Article

Summary.

The development of new molecular and neurobiological methods, computer-assisted quantification techniques and neurobiological investigation methods which can be applied to the human brain, all have evoked an increased demand for post-mortem tissue in research. Psychiatric disorders are considered to be of neurobiological origin. Thus far, however, the etiology and pathophysiology of schizophrenia, depression and dementias are not well understood at the cellular and molecular level. The following will outline the consensus of the working group for neuropsychiatric brain banking organized in the Brainnet Europe II, on ethical guidelines for brain banking, clinical diagnostic criteria, the minimal clinical data set of retrospectively analyzed cases as well as neuropathological standard investigations to perform stageing for neurodegenerative disorders in brain tissue. We will list regions of interest for assessments in psychiatric disorder, propose a dissection scheme and describe preservation and storage conditions of tissue. These guidelines may be of value for future implementations of additional neuropsychiatric brain banks world-wide.

Keywords: Brain bank, post-mortem, schizophrenia, depression, dementia, neuropathology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdolmaleky, HM, Cheng, KH, Russo, A, Smith, CL, Faraone, SV, Wilcox, M, Shafa, R, Glatt, SJ, Nguyen, G, Ponte, JF, Thiagalingam, S, Tsuang, MT 2005Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary reportAm J Med Genet B Neuropsychiatr Genet1346066PubMedGoogle Scholar
  2. Akbarian, S, Sucher, NJ, Bradley, D, Tafazzoli, A, Trinh, D, Hetrick, WP, Potkin, SG, Sandman, CA, Bunney, WE,Jr, Jones, EG 1996Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenicsJ Neurosci161930PubMedGoogle Scholar
  3. Alafuzoff, I, Pikkarainen, M, Al-Sarraj, S, Arzberger, T, Bell, J, Bodi, I, Bogdanovic, N, Budka, H, Bugiani, O, Ferrer, I, Gelpi, E, Giaccone, G, Graeber, MB, Hauw, J, Kamphorst, W, King, A, Kopp, N, Korkolopoulou, P, Kovacs, GG, Meyronet, D, Parchi, P, Patsouris, E, Preusser, M, Ravid, R, Roggendorf, W, Seilhean, D, Streichenberger, N, Thal, DR, Consortium, TB, Kretzschmar, HA 2006Inter-laboratory comparison of assessments of Alzheimer’s disease related lesions. A study of the BrainNet Europe consortiumJ Neuropathol Exp Neurol65740757PubMedGoogle Scholar
  4. Anderson, R, Balls, M, Burke, MD, Cummins, M, Fehily, D, Gray, N, de Groot, MG, Helin, H, Hunt, C, Jones, D, Price, D, Richert, L, Ravid, R, Shute, D, Sladowski, D, Stone, H, Thasler, W, Trafford, J, van der Valk, J, Weiss, T, Womack, C, Ylikomi, T 2001The establishment of human research tissue banking in the UK and several western European countries. The report and recommendations of ECVAM Workshop 44Altern Lab Anim29125134PubMedGoogle Scholar
  5. Arnold, SE, Trojanowski, JQ, Gur, RE, Blackwell, P, Han, LY, Choi, C 1998Absence of neurodegeneration and neural injury in the cerebral cortex in a sample of elderly patients with schizophreniaArch Gen Psychiatry55225232PubMedGoogle Scholar
  6. Baca-Garcia, E, Perez-Rodriguez, MM, Diaz Sastre, C, Saiz-Ruiz, J, de Leon, J 2005Suicidal behavior in schizophrenia and depression: a comparisonSchizophr Res757781PubMedCrossRefGoogle Scholar
  7. Bahn, S, Augood, SJ, Ryan, M, Standaert, DG, Starkey, M, Emson, PC 2001Gene expression profiling in the post-mortem human brain – no cause for dismayJ Chem Neuroanat227994PubMedGoogle Scholar
  8. Baldessarini, RJ, Hegarty, JD, Bird, ED, Benes, FM 1997Meta-analysis of postmortem studies of Alzheimer’s disease-like neuropathology in schizophreniaAm J Psychiatry154861863PubMedGoogle Scholar
  9. Ballard, C, Holmes, C, McKeith, I, Neill, D, O’Brien, J, Cairns, N, Lantos, P, Perry, E, Ince, P, Perry, R 1999Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer’s diseaseAm J Psychiatry15610391045PubMedGoogle Scholar
  10. Banks, RE, Dunn, MJ, Hochstrasser, DF, Sanchez, JC, Blackstock, W, Pappin, DJ, Selby, PJ 2000Proteomics: new perspectives, new biomedical opportunitiesLancet35617491756PubMedGoogle Scholar
  11. Benes, FM, Matzilevich, D, Burke, RE, Walsh, J 2006The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophreniaMol Psychiatry11241251PubMedGoogle Scholar
  12. Bertolote, JM, Fleischmann, A, De Leo, D, Wasserman, D 2004Psychiatric diagnoses and suicide: revisiting the evidenceCrisis25147155PubMedGoogle Scholar
  13. Bielau H, Trubner K, Krell D, Agelink MW, Bernstein HG, Stauch R, Mawrin C, Danos P, Gerhard L, Bogerts B, Baumann B (2005) Volume deficits of subcortical nuclei in mood disorders: a postmortem study. Eur Arch Psychiatry Clin NeurosciGoogle Scholar
  14. Bogerts, B, Meertz, E, Schonfeldt-Bausch, R 1985Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkageArch Gen Psychiatry42784791PubMedGoogle Scholar
  15. Braak, H, Braak, E 1991aDemonstration of amyloid deposits and neurofibrillary changes in whole brain sectionsBrain Pathol1213216Google Scholar
  16. Braak, H, Braak, E 1991bNeuropathological stageing of Alzheimer-related changesActa Neuropathol82239259Google Scholar
  17. Braak, H, Braak, E 1991cNeuropathological stageing of Alzheimer-related changesActa Neuropathol (Berl)82239259Google Scholar
  18. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). J Neurol 249 Suppl 3: III/1–5Google Scholar
  19. Braak, H, Rub, U, Jansen Steur, EN, Del Tredici, K, de Vos, RA 2005Cognitive status correlates with neuropathologic stage in Parkinson diseaseNeurology6414041410PubMedGoogle Scholar
  20. Brodmann K (1925) Vergleichende Lokalisationslehre der Großhirnrinde. BarthGoogle Scholar
  21. Buesa, C, Maes, T, Subirada, F, Barrachina, M, Ferrer, I 2004DNA chip technology in brain banks: confronting a degrading worldJ Neuropathol Exp Neurol6310031014PubMedGoogle Scholar
  22. Bushe, C, Holt, R 2004Prevalence of diabetes and impaired glucose tolerance in patients with schizophreniaBr J PsychiatrySuppl 47S67S71Google Scholar
  23. Campbell, S, Macqueen, G 2004The role of the hippocampus in the pathophysiology of major depressionJ Psychiatry Neurosci29417426PubMedGoogle Scholar
  24. Carlsson, A, Hansson, LO, Waters, N, Carlsson, ML 1997Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implicationsLife Sci617594PubMedGoogle Scholar
  25. Chakos, MH, Alvir, JM, Woerner, MG, Koreen, A, Geisler, S, Mayerhoff, D, Sobel, S, Kane, JM, Borenstein, M, Lieberman, JA 1996Incidence and correlates of tardive dyskinesia in first episode of schizophreniaArch Gen Psychiatry53313319PubMedGoogle Scholar
  26. Chakos, MH, Lieberman, JA, Alvir, J, Bilder, R, Ashtari, M 1995Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapineLancet345456457PubMedGoogle Scholar
  27. Chambers, JS, Thomas, D, Saland, L, Neve, RL, Perrone-Bizzozero, NI 2004Growth-associated protein 43 (GAP-43) and synaptophysin alterations in the dentate gyrus of patients with schizophreniaProg Neuropsychopharmacol Biol Psychiatry29283290PubMedGoogle Scholar
  28. Chen, J, Lipska, BK, Halim, N, Ma, QD, Matsumoto, M, Melhem, S, Kolachana, BS, Hyde, TM, Herman, MM, Apud, J, Egan, MF, Kleinman, JE, Weinberger, DR 2004Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brainAm J Hum Genet75807821PubMedGoogle Scholar
  29. Chua, SE, Murray, RM 1996The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychologyAnn Med28547555PubMedGoogle Scholar
  30. Clark D, Dedova I, Cordwell S, Matsumoto I (2006) A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry 11: 459–470, 423Google Scholar
  31. Crow, TJ 1990Temporal lobe asymmetries as the key to the etiology of schizophreniaSchizophr Bull16433443PubMedGoogle Scholar
  32. Crow, TJ 1995Brain changes and negative symptoms in schizophreniaPsychopathology281821PubMedGoogle Scholar
  33. Cruz-Sanchez, FF, Mordini, E, Ravid, R 1997Ethical aspects to be considered in brain bankingAnn Ist Super Sanita33477482PubMedGoogle Scholar
  34. Damadzic, R, Shuangshoti, S, Giblen, G, Herman, MM 2002Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depressionActa Neuropathol (Berl)103488494Google Scholar
  35. Danos, P, Baumann, B, Bernstein, HG, Stauch, R, Krell, D, Falkai, P, Bogerts, B 2002The ventral lateral posterior nucleus of the thalamus in schizophrenia: a post-mortem studyPsychiatry Res11419PubMedGoogle Scholar
  36. Danos, P, Baumann, B, Kramer, A, Bernstein, HG, Stauch, R, Krell, D, Falkai, P, Bogerts, B 2003Volumes of association thalamic nuclei in schizophrenia: a postmortem studySchizophr Res60141155PubMedGoogle Scholar
  37. Dempster, EL, Mill, J, Craig, IW, Collier, DA 2006The quantification of COMT mRNA in postmortem cerebellum tissue: diagnosis, genotype, methylation and expressionBMC Med Genet710PubMedGoogle Scholar
  38. Deng, C, Huang, XF 2006Increased density of GABAA receptors in the superior temporal gyrus in schizophreniaExp Brain Res168587590PubMedGoogle Scholar
  39. Digney, A, Keriakous, D, Scarr, E, Thomas, E, Dean, B 2005Differential changes in apolipoprotein E in schizophrenia and bipolar I disorderBiol Psychiatry57711715PubMedGoogle Scholar
  40. Dracheva, S, Elhakem, SL, McGurk, SR, Davis, KL, Haroutunian, V 2004GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophreniaJ Neurosci Res76581592PubMedGoogle Scholar
  41. Dwork, AJ, Susser, ES, Keilp, J, Waniek, C, Liu, D, Kaufman, M, Zemishlany, Z, Prohovnik, I 1998Senile degeneration and cognitive impairment in chronic schizophreniaAm J Psychiatry15515361543PubMedGoogle Scholar
  42. Eberwine, J 2001Single-cell molecular biologyNat Neurosci411551156PubMedGoogle Scholar
  43. Falkai, P, Bogerts, B, Schneider, T, Greve, B, Pfeiffer, U, Pilz, K, Gonsiorzcyk, C, Majtenyi, C, Ovary, I 1995Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem studySchizophr Res14161176PubMedGoogle Scholar
  44. Falkai, P, Honer, WG, Alfter, D, Schneider-Axmann, T, Bussfeld, P, Cordes, J, Blank, B, Schonell, H, Steinmetz, H, Maier, W, Tepest, R 2002The temporal lobe in schizophrenia from uni- and multiply affected familiesNeurosci Lett3252528PubMedGoogle Scholar
  45. Falkai, P, Schneider-Axmann, T, Honer, WG 2000Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormalityBiol Psychiatry47937943PubMedGoogle Scholar
  46. Ferrer, I, Barrachina, M, Puig, B 2002Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grainsActa Neuropathol (Berl)104658664Google Scholar
  47. Fossati, P, Radtchenko, A, Boyer, P 2004Neuroplasticity: from MRI to depressive symptomsEur Neuropsychopharmacol14S503S510PubMedGoogle Scholar
  48. Frisoni, GB, Galluzzi, S, Riello, R 2005Prescription and choice of diagnostic imaging by physician specialty in Alzheimer’s Centers (Unita di Valutazione Alzheimer – UVA) in Northern ItalyAging Clin Exp Res171419PubMedGoogle Scholar
  49. Ginsberg, SD, Che, S 2002RNA amplification in brain tissuesNeurochem Res27981992PubMedGoogle Scholar
  50. Gsell, W, Lange, KW, Pfeuffer, R, Heckers, S, Heinsen, H, Senitz, D, Jellinger, K, Ransmayr, G, Wichart, I, Vock, R,  et al. 1993How to run a brain bank. A report from the Austro-German brain bankJ Neural TransmSuppl 393170Google Scholar
  51. Hafner H (2000) Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand Suppl: 44–48Google Scholar
  52. Hakak, Y, Walker, JR, Li, C, Wong, WH, Davis, KL, Buxbaum, JD, Haroutunian, V, Fienberg, AA 2001Genome-wide expression analysis reveals dysregulation of myelination- related genes in chronic schizophreniaProc Natl Acad Sci USA9847464751PubMedGoogle Scholar
  53. Harrison, PJ, Owen, MJ 2003Genes for schizophrenia? Recent findings and their pathophysiological implicationsLancet361417419PubMedGoogle Scholar
  54. Healy, DJ, Sima, AA, Tapp, A, Watson, SJ, Meador-Woodruff, JH 1996Frequency of neuropathology in a brain bank from a long-term, domiciliary populationJ Psychiatr Res304549PubMedGoogle Scholar
  55. Heckers, S 1997Neuropathology of schizophrenia: cortex, thalamus, basal ganglia, and neurotransmitter-specific projection systemsSchizophr Bull23403421PubMedGoogle Scholar
  56. Henn, FA, Braus, DF 1999Structural neuroimaging in schizophrenia. An integrative view of neuromorphologyEur Arch Psychiatry Clin Neurosci2494856PubMedGoogle Scholar
  57. Higaki, J, Murphy, GM,Jr, Cordell, B 1997Inhibition of beta-amyloid formation by haloperidol: a possible mechanism for reduced frequency of Alzheimer’s disease pathology in schizophreniaJ Neurochem68333336PubMedCrossRefGoogle Scholar
  58. Hiller, W, Dichtl, G, Hecht, H, Hundt, W, von Zerssen, D 1993An empirical comparison of diagnoses and reliabilities in ICD-10 and DSM-III-REur Arch Psychiatry Clin Neurosci242209217PubMedGoogle Scholar
  59. Honer, WG, Falkai, P, Bayer, TA, Xie, J, Hu, L, Li, HY, Arango, V, Mann, JJ, Dwork, AJ, Trimble, WS 2002Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illnessCereb Cortex12349356PubMedGoogle Scholar
  60. Hyman, BT, Trojanowski, JQ 1997Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer diseaseJ Neuropathol Exp Neurol5610951097PubMedGoogle Scholar
  61. Ironside, JW, McCardle, L, Horsburgh, A, Lim, Z, Head, MW 2002Pathological diagnosis of variant Creutzfeldt-Jakob diseaseApmis1107987PubMedGoogle Scholar
  62. Jellinger, K 1985Neuromorphological background of pathochemical studies in major psychosesBeckmann, HRiederer, P eds. Pathochemical markers in major psychosesSpringerBerlin Heidelberg New York123Google Scholar
  63. Jellinger, K 2001Frequency of “dementia of unknown etiology” increases with ageArch Neurol5814981499PubMedGoogle Scholar
  64. Jellinger K, Riederer P, Tomonaga M (1980) Progressive supranuclear palsy: clinico-pathological and biochemical studies. J Neural Transm Suppl: 111–128Google Scholar
  65. Johnstone, EC, Crow, TJ, Frith, CD, Husband, J, Kreel, L 1976Cerebral ventricular size and cognitive impairment in chronic schizophreniaLancet2924926PubMedGoogle Scholar
  66. Johnston-Wilson, NL, Bouton, CM, Pevsner, J, Breen, JJ, Torrey, EF, Yolken, RH 2001Emerging technologies for large-scale screening of human tissues and fluids in the study of severe psychiatric diseaseInt J Neuropsychopharmacol48392PubMedGoogle Scholar
  67. Kamme, F, Salunga, R, Yu, J, Tran, DT, Zhu, J, Luo, L, Bittner, A, Guo, HQ, Miller, N, Wan, J, Erlander, M 2003Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneityJ Neurosci2336073615PubMedGoogle Scholar
  68. Kertesz, A, McMonagle, P, Blair, M, Davidson, W, Munoz, DG 2005The evolution and pathology of frontotemporal dementiaBrain12819962005PubMedGoogle Scholar
  69. Konradi, C 2005Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysisBrain Res Brain Res Rev50142155PubMedGoogle Scholar
  70. Kovelman, JA, Scheibel, AB 1984A neurohistological correlate of schizophreniaBiol Psychiatry1916011621PubMedGoogle Scholar
  71. Kozlovsky, N, Scarr, E, Dean, B, Agam, G 2006Postmortem brain calcineurin protein levels in schizophrenia patients are not different from controlsSchizophr Res83173177PubMedGoogle Scholar
  72. Kruijshaar, ME, Hoeymans, N, Spijker, J, Stouthard, ME, Essink-Bot, ML 2005Has the burden of depression been overestimated?Bull World Health Organ83443448PubMedGoogle Scholar
  73. Laifenfeld, D, Karry, R, Klein, E, Ben-Shachar, D 2005Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem studyBiol Psychiatry57716725PubMedGoogle Scholar
  74. Leonardi, O, Mints, G, Hussain, MA 2003Beta-cell apoptosis in the pathogenesis of human type 2 diabetes mellitusEur J Endocrinol14999102PubMedGoogle Scholar
  75. Liang, P, Pardee, AB 1992Differential display of eukaryotic messenger RNA by means of the polymerase chain reactionScience257967971PubMedGoogle Scholar
  76. Malberg, JE, Schechter, LE 2005Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugsCurr Pharm Des11145155PubMedGoogle Scholar
  77. Marcotte, ER, Srivastava, LK, Quirion, R 2001DNA microarrays in neuropsychopharmacologyTrends Pharmacol Sci22426436PubMedGoogle Scholar
  78. Marcotte, ER, Srivastava, LK, Quirion, R 2003cDNA microarray and proteomic approaches in the study of brain diseases: focus on schizophrenia and Alzheimer’s diseasePharmacol Ther1006374PubMedGoogle Scholar
  79. McKeith, IG, Galasko, D, Kosaka, K, Perry, EK, Dickson, DW, Hansen, LA, Salmon, DP, Lowe, J, Mirra, SS, Byrne, EJ, Lennox, G, Quinn, NP, Edwardson, JA, Ince, PG, Bergeron, C, Burns, A, Miller, BL, Lovestone, S, Collerton, D, Jansen, EN, Ballard, C, de Vos, RA, Wilcock, GK, Jellinger, KA, Perry, RH 1996Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshopNeurology4711131124PubMedGoogle Scholar
  80. Meeuwsen, S, Bsibsi, M, Persoon-Deen, C, Ravid, R, van Noort, JM 2005Cultured human adult microglia from different donors display stable cytokine, chemokine and growth factor gene profiles but respond differently to a pro-inflammatory stimulusNeuroimmunomodulation12235245PubMedGoogle Scholar
  81. Mendez, MF, Mastri, AR, Sung, JH, Zander, BA, Frey, WH,2nd 1991Neuropathologically confirmed Alzheimer’s disease: clinical diagnoses in 394 casesJ Geriatr Psychiatry Neurol42629PubMedGoogle Scholar
  82. Middleton, FA, Peng, L, Lewis, DA, Levitt, P, Mirnics, K 2005Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophreniaNeuropsychopharmacology30974983PubMedGoogle Scholar
  83. Mirra, SS, Heyman, A, McKeel, D, Sumi, SM, Crain, BJ, Brownlee, LM, Vogel, FS, Hughes, JP, van Belle, G, Berg, L 1991The consortium to establish a registry for Alzheimer’s disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s diseaseNeurology41479486PubMedGoogle Scholar
  84. Morgello, S, Estanislao, L, Simpson, D, Geraci, A, DiRocco, A, Gerits, P, Ryan, E, Yakoushina, T, Khan, S, Mahboob, R, Naseer, M, Dorfman, D, Sharp, V 2004HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV brain bankArch Neurol61546551PubMedGoogle Scholar
  85. Nestler, EJ, Barrot, M, DiLeone, RJ, Eisch, AJ, Gold, SJ, Monteggia, LM 2002Neurobiology of depressionNeuron341325PubMedGoogle Scholar
  86. Olesen, J, Leonardi, M 2003The burden of brain diseases in EuropeEur J Neurol10471477PubMedGoogle Scholar
  87. Olney, JW, Farber, NB 1995Glutamate receptor dysfunction and schizophreniaArch Gen Psychiatry529981007PubMedGoogle Scholar
  88. Papapetropoulos, S, Gonzalez, J, Lieberman, A, Villar, JM, Mash, DC 2005Dementia in Parkinson’s disease: a post-mortem study in a population of brain donorsInt J Geriatr Psychiatry20418422PubMedGoogle Scholar
  89. Paykel, ES, Brugha, T, Fryers, T 2005Size and burden of depressive disorders in EuropeEur Neuropsychopharmacol15411423PubMedGoogle Scholar
  90. Przuntek, H, Muller, T, Riederer, P 2004Diagnostic staging of Parkinson’s disease: conceptual aspectsJ Neural Transm111201216PubMedGoogle Scholar
  91. Purohit, DP, Perl, DP, Haroutunian, V, Powchik, P, Davidson, M, Davis, KL 1998Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 casesArch Gen Psychiatry55205211PubMedGoogle Scholar
  92. Ravid, R, Swaab, DF 1993The Netherlands brain bank – a clinico-pathological link in aging and dementia researchJ Neural TransmSuppl 39143153Google Scholar
  93. Ravid, R, Van Zwieten, EJ, Swaab, DF 1992Brain banking and the human hypothalamus – factors to match for, pitfalls and potentialsProg Brain Res938395PubMedCrossRefGoogle Scholar
  94. Ravid, R, Swaab, DF, Kamphorst, W, Zwieten, EJV 1995A golden standard protocol for the brain banking society?Neuropathol. Exp Neurol542526Google Scholar
  95. Rehm, J, Room, R, van den Brink, W, Jacobi, F 2005Alcohol use disorders in EU countries and Norway: an overview of the epidemiologyEur Neuropsychopharmacol15377388PubMedGoogle Scholar
  96. Reynolds, GP, Abdul-Monim, Z, Neill, JC, Zhang, ZJ 2004Calcium binding protein markers of GABA deficits in schizophrenia – postmortem studies and animal modelsNeurotox Res65761PubMedCrossRefGoogle Scholar
  97. Riederer, P, Gsell, W, Calza, L, Franzek, E, Jungkunz, G, Jellinger, K, Reynolds, GP, Crow, T, Cruz-Sanchez, FF, Beckmann, H 1995Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for postmortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I)J Neural Transm Gen Sect102255264PubMedGoogle Scholar
  98. Ritchie, K, Lovestone, S 2002The dementiasLancet36017591766PubMedGoogle Scholar
  99. Sagerstrom, CG, Sun, BI, Sive, HL 1997Subtractive cloning: past, present, and futureAnnu Rev Biochem66751783PubMedGoogle Scholar
  100. Scarr, E, Beneyto, M, Meador-Woodruff, JH, Deans, B 2005Cortical glutamatergic markers in schizophreniaNeuropsychopharmacology3015211531PubMedGoogle Scholar
  101. Schiavi, SC, Wellington, CL, Shyu, AB, Chen, CY, Greenberg, ME, Belasco, JG 1994Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translationJ Biol Chem26934413448PubMedGoogle Scholar
  102. Schmitt, A, Weber, S, Jatzko, A, Braus, DF, Henn, FA 2004aHippocampal volume and cell proliferation after acute and chronic clozapine or haloperidol treatmentJ Neural Transm11191100Google Scholar
  103. Schmitt, A, Wilczek, K, Blennow, K, Maras, A, Jatzko, A, Petroianu, G, Braus, DF, Gattaz, WF 2004bAltered thalamic membrane phospholipids in schizophrenia: a postmortem studyBiol Psychiatry564145Google Scholar
  104. Schmitz, C, Hof, PR 2005Design-based stereology in neuroscienceNeuroscience130813831PubMedGoogle Scholar
  105. Selemon, LD, Mrzljak, J, Kleinman, JE, Herman, MM, Goldman-Rakic, PS 2003Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca’s area 44 and area 9Arch Gen Psychiatry606977PubMedCrossRefGoogle Scholar
  106. Shastry, S, Moning, L, Tyagi, N, Steed, M, Tyagi, SC 2005GABA receptors and nitric oxide ameliorate constrictive collagen remodeling in hyperhomocysteinemiaJ Cell Physiol205422427PubMedGoogle Scholar
  107. Shenton, ME, Dickey, CC, Frumin, M, McCarley, RW 2001A review of MRI findings in schizophreniaSchizophr Res49152PubMedGoogle Scholar
  108. Shirts, BH, Nimgaonkar, V 2004The genes for schizophrenia: finally a breakthrough?Curr Psychiatry Rep6303312PubMedGoogle Scholar
  109. Smesny, S, Kinder, D, Willhardt, I, Rosburg, T, Lasch, J, Berger, G, Sauer, H 2005Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophreniaBiol Psychiatry57399405PubMedGoogle Scholar
  110. Stolle, CA, Benz, EJ,Jr 1988Cellular factor affecting the stability of beta-globin mRNAGene626574PubMedGoogle Scholar
  111. Supprian, T, Reiche, W, Schmitz, B, Grunwald, I, Backens, M, Hofmann, E, Georg, T, Falkai, P, Reith, W 2004MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controlsPsychiatry Res131269276PubMedGoogle Scholar
  112. Sweet, RA, Hamilton, RL, Butters, MA, Mulsant, BH, Pollock, BG, Lewis, DA, Lopez, OL, DeKosky, ST, Reynolds, CF,3rd 2004Neuropathologic correlates of late-onset major depressionNeuropsychopharmacology2922422250PubMedGoogle Scholar
  113. Thal, DR, Rub, U, Orantes, M, Braak, H 2002Phases of A beta-deposition in the human brain and its relevance for the development of ADNeurology581791800Google Scholar
  114. Tsuji, T, Shiozaki, A, Kohno, R, Yoshizato, K, Shimohama, S 2002Proteomic profiling and neurodegeneration in Alzheimer’s diseaseNeurochem Res2712451253PubMedGoogle Scholar
  115. Velculescu, VE, Zhang, L, Vogelstein, B, Kinzler, KW 1995Serial analysis of gene expressionScience270484487PubMedGoogle Scholar
  116. Weickert, CS, Straub, RE, McClintock, BW, Matsumoto, M, Hashimoto, R, Hyde, TM, Herman, MM, Weinberger, DR, Kleinman, JE 2004Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrainArch Gen Psychiatry61544555PubMedGoogle Scholar
  117. Will, RG, Zeidler, M, Stewart, GE, Macleod, MA, Ironside, JW, Cousens, SN, Mackenzie, J, Estibeiro, K, Green, AJ, Knight, RS 2000Diagnosis of new variant Creutzfeldt-Jakob diseaseAnn Neurol47575582PubMedGoogle Scholar
  118. Wilson, GM, Flibotte, S, Chopra, V, Melnyk, BL, Honer, WG, Holt, RA 2006DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signalingHum Mol Genet15743749PubMedGoogle Scholar
  119. Wright, IC, Rabe-Hesketh, S, Mellers, J, Bullmore, ET 2000aTesting for laterality differences in regional brain volumesArch Gen Psychiatry57511512Google Scholar
  120. Wright, IC, Rabe-Hesketh, S, Woodruff, PW, David, AS, Murray, RM, Bullmore, ET 2000bMeta-analysis of regional brain volumes in schizophreniaAm J Psychiatry1571625Google Scholar
  121. Yao, JK, Leonard, S, Reddy, RD 2000Membrane phospholipid abnormalities in postmortem brains from schizophrenic patientsSchizophr Res42717PubMedGoogle Scholar
  122. Zeidler, M, Sellar, RJ, Collie, DA, Knight, R, Stewart, G, Macleod, MA, Ironside, JW, Cousens, S, Colchester, AC, Hadley, DM, Will, RG 2000The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob diseaseLancet35514121418PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • A. Schmitt
    • 1
    • 2
  • M. Bauer
    • 3
  • H. Heinsen
    • 4
  • W. Feiden
    • 5
  • The Consortium of Brainnet Europe II
  • P. Falkai
    • 1
  • I. Alafuzoff
    • 6
  • T. Arzberger
    • 7
  • S. Al-Sarraj
    • 8
  • J. E. Bell
    • 9
  • N. Bogdanovic
    • 10
  • W. Brück
    • 11
  • H. Budka
    • 12
  • I. Ferrer
    • 13
  • G. Giaccone
    • 14
  • G. G. Kovacs
    • 15
  • D. Meyronet
    • 16
  • M. Palkovits
    • 17
  • P. Parchi
    • 18
  • E. Patsouris
    • 19
  • R. Ravid
    • 20
  • R. Reynolds
    • 21
  • P. Riederer
    • 22
  • W. Roggendorf
    • 23
  • A. Schwalber
    • 24
  • D. Seilhean
    • 25
  • H. Kretzschmar
    • 7
  1. 1.Department of PsychiatryUniversity of GöttingenGöttingenGermany
  2. 2.Central Institute of Mental HealthMannheimGermany
  3. 3.Department of NeuropathologyUniversity of LeipzigLeipzigGermany
  4. 4.Morphological Brain Research UnitUniversity of WürzburgWürzburgGermany
  5. 5.Department of NeuropathologyUniversity of SaarlandHomburgGermany
  6. 6.Department of Neuroscience and NeurologyUniversity of KuopioKuopioFinland
  7. 7.Institute of NeuropathologyLudwig Maximilians University MunichMunichGermany
  8. 8.King’s College LondonLondonUnited Kingdom
  9. 9.Institute of NeuropathologyUniversity of EdinburghEdinburghUnited Kingdom
  10. 10.Karolinska Institute, Neurotec, GeriatricHuddinge Brain Bank, NOVUMStockholmSweden
  11. 11.Department of NeuropathologyUniversity of GöttingenGöttingenGermany
  12. 12.Institute of NeurologyMedical University of ViennaWienAustria
  13. 13.Institute of Neuropathology, Hospital de BellvitgeUniversity of BarcelonaBarcelonaSpain
  14. 14.Division of Neuropathology and NeurologyNational Institute of Neurology Carlo BestaMilanoItaly
  15. 15.National Institute of Psychiatry and NeurologyBudapestHungary
  16. 16.Neuropathology, Department of PathologyNeurological HospitalCHU de LyonFrance
  17. 17.Human Brain Tissue Bank BudapestBudapestHungary
  18. 18.Department of Neurological ScienceUniversity of BolognaBolognaItaly
  19. 19.Department of PathologyNational and Capodistrian University of AthensAthensGreece
  20. 20.Netherlands Brain BankAmsterdamNetherlands
  21. 21.Imperial College of Technology and MedicineLondonUnited Kingdom
  22. 22.Institute of Clinical Neurochemistry and NPF-Center of Excellence Laboratories, Clinic for Psychiatry and PsychotherapyUniversity of WürzburgWürzburgGermany
  23. 23.Department of Neuropathology, Institute of PathologyUniversity of WürzburgWürzburgGermany
  24. 24.GABO:mi mbH & Co.KGMunichGermany
  25. 25.Laboratory of NeuropathologyUniversity Pierre et Marie CurieParisFrance

Personalised recommendations